TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment

seekingalpha09-11

TFF Pharmaceuticals (NASDAQ:TFFP) shares jumped around 13% premarket on Wednesday after it entered a partnership with Emory University and the Biomedical Advanced Research and Development Authority (...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2466284801?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-11 19:28","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2466284801","market":"sh","top_or_hot":-1,"title":"TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment","media":"seekingalpha","content":"<div>\n<p>TFF Pharmaceuticals (NASDAQ:TFFP) shares jumped around 13% premarket on Wednesday after it entered a partnership with Emory University and the Biomedical Advanced Research and Development Authority (...</p>\n\n<a href=\"https://seekingalpha.com/news/4148607-tff-pharmaceuticals-enters-pact-for-dry-powder-mrna-based-covid-treatment\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-11 19:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4148607-tff-pharmaceuticals-enters-pact-for-dry-powder-mrna-based-covid-treatment><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TFF Pharmaceuticals (NASDAQ:TFFP) shares jumped around 13% premarket on Wednesday after it entered a partnership with Emory University and the Biomedical Advanced Research and Development Authority (...</p>\n\n<a href=\"https://seekingalpha.com/news/4148607-tff-pharmaceuticals-enters-pact-for-dry-powder-mrna-based-covid-treatment\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://seekingalpha.com/news/4148607-tff-pharmaceuticals-enters-pact-for-dry-powder-mrna-based-covid-treatment","article_id":"2466284801","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466284801","pubTimestamp":1726054116,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"TFF Pharmaceuticals  shares jumped around 13% premarket on Wednesday after it entered a partnership with Emory University and the Biomedical Advanced Research and Development Authority  to develop a dry powder inhaled mRNA-based treatment for influenza and Covid. Under the partnership, funded by BARDA and other U.S. government agencies, TFF Pharmaceuticals will test the feasibility of converting Emory’s mRNA-based Cas13a antiviral against influenza A and B and SARS-CoV-2 into a dry powder formulation for more precise inhalational delivery, improved stability and widespread distribution without the need for cold-chain storage. TFF Pharmaceuticals CEO Harlan Weisman said, “Inhalational delivery of antiviral therapy against respiratory viruses is poised to drive efficacy by providing the drug where the virus replicates while improved stability and room temperature storage enhance practicality for widespread distribution.”","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","TFFP":"TFF Pharmaceuticals"},"translate_title":"TFF Pharmaceuticals签订基于干粉mRNA的Covid治疗协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TFFP":1},"content_text":"TFF Pharmaceuticals (NASDAQ:TFFP) shares jumped around 13% premarket on Wednesday after it entered a partnership with Emory University and the Biomedical Advanced Research and Development Authority (BARDA) to develop a dry powder inhaled mRNA-based treatment for influenza and Covid. Under the partnership, funded by BARDA and other U.S. government agencies, TFF Pharmaceuticals will test the feasibility of converting Emory’s mRNA-based Cas13a antiviral against influenza A and B and SARS-CoV-2 into a dry powder formulation for more precise inhalational delivery, improved stability and widespread distribution without the need for cold-chain storage. TFF Pharmaceuticals CEO Harlan Weisman said, “Inhalational delivery of antiviral therapy against respiratory viruses is poised to drive efficacy by providing the drug where the virus replicates while improved stability and room temperature storage enhance practicality for widespread distribution.”","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466284801"}